MetaCap

ARS Pharmaceuticals (SPRY) News

NASDAQ: SPRYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.96-0.40 (-11.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SPRY news summary

We found 4 recent headlines mentioning ARS Pharmaceuticals (SPRY): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. SPRY is making an outsized move today, down 11.90% at $2.96, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "ARS Pharma (SPRY) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ARS Pharmaceuticals headlines

Compare SPRY